Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

NCT00034125 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: LY353381
DRUG: tamoxifen

Sponsor

Eli Lilly and Company